Related Experiment Video
Updated: Oct 4, 2025

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
The Need for Adult Pneumococcal Vaccination in Nigeria
Erhabor Gregory1, Sulaimon Alani2, Egbagbe Eruke3
1Professor of Medicine, Obafemi Awolowo University and Consultant Pulmonologist, Head, Chest Unit, Obafemi Awolowo University Teaching Hospital, Ile Ife.
Abstract:
Despite universal immunization coverage on a global scale among children, the vast majority of immunocompromised adults, and particularly the elderly, remain unvaccinated. Considering that a significant proportion of mortality from pneumococcal disease occurs among the elderly, preventive measures through pneumococcal vaccination in adults, especially the elderly with co-morbidities, needs to be urgently explored and implemented in Africa, and particularly in Nigeria, to stem the tide of deaths resulting from pneumococcal disease among this population. This article looks at the pneumococcal epidemiology and burden of disease in Nigeria, as well as the vaccines available and the rationale for adult pneumococcal vaccination. It also highlights the potential barriers to use and makes recommendations to overcome these barriers and improve acceptance in Nigeria.
More Related Videos
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Vaccinations

